(Q37258361)

19 August 2017

1 reference

title

A review of high-risk prostate cancer and the role of neo-adjuvant and adjuvant therapies (English)

1 reference

19 August 2017

1 reference

Joshua R Gonzalez

1

1 reference

19 August 2017

Melissa A Laudano

2

1 reference

19 August 2017

Tara R McCann

3

1 reference

19 August 2017

James M McKiernan

4

1 reference

19 August 2017

Mitchell C Benson

5

1 reference

19 August 2017

language of work or name

1 reference

2 September 2008

1 reference

19 August 2017

published in

World Journal of Urology

1 reference

19 August 2017

volume

26

1 reference

19 August 2017

issue

5

1 reference

19 August 2017

page(s)

475-480

1 reference

Impact of fellowship training on pathologic outcomes and complication rates of radical prostatectomy

19 August 2017

cites work

1 reference

12 December 2020

Changing patterns of pelvic lymphadenectomy for prostate cancer: results from CaPSURE.

1 reference

12 December 2020

The role of lymphadenectomy in prostate cancer

1 reference

12 December 2020

Adjuvant weekly docetaxel for patients with high risk prostate cancer after radical prostatectomy: a multi-institutional pilot study

1 reference

12 December 2020

Cancer and Leukemia Group B (CALGB) 90203: a randomized phase 3 study of radical prostatectomy alone versus estramustine and docetaxel before radical prostatectomy for patients with high-risk localized disease

1 reference

12 December 2020

Long-term survival in men with high grade prostate cancer: a comparison between conservative treatment, radiation therapy and radical prostatectomy--a propensity scoring approach

1 reference

12 December 2020

Natural history of progression after PSA elevation following radical prostatectomy

1 reference

12 December 2020

Local control and long-term disease-free survival for stage D1 (T2-T4N1-N2M0) prostate cancer after radical prostatectomy in the PSA era

1 reference

12 December 2020

Management of Stage D1 Adenocarcinoma of the Prostate: The Johns Hopkins Experience 1974 to 1987

1 reference

12 December 2020

An interdisciplinary approach to treating prostate cancer

1 reference

12 December 2020

Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer

1 reference

12 December 2020

Anatomical extent of lymph node dissection: impact on men with clinically localized prostate cancer

1 reference

12 December 2020

Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911)

1 reference

12 December 2020

Is a limited lymph node dissection an adequate staging procedure for prostate cancer?

1 reference

12 December 2020

High-risk, clinically localized prostate cancer: is monotherapy adequate?

1 reference

12 December 2020

Intermediate-Term Survival Results in Clinically Understaged Prostate Cancer Patients Following Radical Prostatectomy

1 reference

12 December 2020

Neoadjuvant docetaxel and estramustine chemotherapy in high-risk/locally advanced prostate cancer.

1 reference

12 December 2020

A phase 3 randomized controlled trial of the efficacy and safety of atrasentan in men with metastatic hormone-refractory prostate cancer

1 reference

12 December 2020

Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial

1 reference

12 December 2020

Prognosis of patients with lymph node positive prostate cancer following radical prostatectomy: long-term results

1 reference

12 December 2020

10.1007/S00345-008-0314-8

Identifiers

DOI

1 reference

19 August 2017

1 reference